Wiley-Blackwell announces launch of 'Microbial Biotechnology'
Oxford, UK, August 29, 2007 — Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc, and the Society for Applied Microbiology (SfAM) announced today publication of the first articles for Microbial Biotechnology. The new international journal will focus on advances in the expanding field of biotechnology. The first issue of the journal will publish in January 2008 via Blackwell Synergy (www.blackwell-synergy.com). All articles will be free of charge for the first year of publication.
“More than 90% of microbial diversity still remains to be discovered. It is this new biodiversity that will become the treasure chest of new and improved biotechnological developments and applications in the sectors of chemicals, pharmaceuticals, energy, mining, materials, agriculture, food, and environmental protection,” said Professor Ken Timmis, Founding Editor of Microbial Biotechnology. “This new journal has been created to harness original research reporting advances belonging to the upper 25% in the field in any aspect of microbial applications.”
Each issue of the journal will contain the highest-quality original research papers on topics such as green chemistry, bioenergy, agriculture, pharmaceuticals, metabolic design, diagnostics, systems analysis, and protein engineering. In addition, the journal will feature regular special issues edited by guest editors, genomic updates, and webalerts, a selection of web sites relevant to topics in microbial biotechnology. For more information about the journal, visit www.microbialbiotech.com.
The addition of this journal strengthens Wiley-Blackwell’s leading position in microbiology. “Wiley-Blackwell has a longstanding relationship with the SfAM to publish their premier microbiology journals,” said Mike Davis, PhD, Managing Director and Vice President, Life Sciences, Wiley-Blackwell. “This new journal is an exciting opportunity for us to enhance our existing partnership with SfAM and together we will expand the global reach and visibility of Microbial Biotechnology.”
John Wiley & Sons, Inc. August 2007.
rating: 3.00 from 1 votes | updated on: 12 Dec 2007 | views: 1746 |